CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $49,999,983
- in 2 filings
- Open-market sales, last 90 days
- $215,781
- in 9 filings
Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 41 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Bulis Veronica Sanchez VP, Corporate Controller | Sale | −416 | $15.93 | $7K | 14,383 |
| 2026-11-10 | Lee Gary K. Chief Scientific Officer | Sale | −129 | $15.93 | $2K | 16,091 |
| 2026-11-10 | Hill Stephen J. Chief Operating Officer | Sale | −88 | $15.93 | $1K | 16,728 |
| 2026-11-10 | Seely Lynn President and CEO | Sale | −545 | $15.93 | $9K | 63,354 |
| 2026-10-12 | Aguirre Jarrad Mattieu Chief Medical Officer | Sale | −422 | $8.63 | $4K | 19,857 |
| 2026-09-10 | Shook David Chief Medical Officer | Sale | −500 | $12.70 | $6K | 20,423 |
| 2026-08-21 | Lee Gary K. Chief Scientific Officer | Sale | −1,457 | $15.54 | $23K | 16,220 |
| 2026-08-21 | Hill Stephen J. Chief Operating Officer | Sale | −989 | $15.54 | $15K | 16,816 |
| 2026-08-21 | Seely Lynn President and CEO | Sale | −9,589 | $15.54 | $149K | 63,899 |
| 2026-08-10 | Bulis Veronica Sanchez VP, Corporate Controller | Sale | −621 | $14.34 | $9K | 14,799 |
| 2026-08-10 | Lee Gary K. Chief Scientific Officer | Sale | −131 | $14.34 | $2K | 17,677 |
| 2026-08-10 | Hill Stephen J. Chief Operating Officer | Sale | −89 | $14.34 | $1K | 17,805 |
| 2026-08-10 | Seely Lynn President and CEO | Sale | −390 | $14.34 | $6K | 73,488 |
| 2026-07-17 | Innovative Cellular Therapeutics Holdings Ltd 10% owner | Sale 10b5-1 | −10 | $13.70 | $137 | 2,857,480 |
| 2026-07-16 | Innovative Cellular Therapeutics Holdings Ltd 10% owner | Sale 10b5-1 | −10 | $13.73 | $137 | 2,857,490 |
| 2026-06-10 | Shook David Chief Medical Officer | Sale | −1,977 | $12.64 | $25K | 20,923 |
| 2026-05-11 | Bulis Veronica Sanchez VP, Corporate Controller | Sale | −217 | $18.91 | $4K | 15,420 |
| 2026-05-11 | Lee Gary K. Chief Scientific Officer | Sale | −130 | $18.92 | $2K | 17,808 |
| 2026-05-11 | Hill Stephen J. Chief Operating Officer | Sale | −89 | $18.92 | $2K | 17,894 |
| 2026-05-11 | Seely Lynn President and CEO | Sale | −388 | $18.91 | $7K | 73,878 |
Page 1 of 3 · 45 trades